Sepsis is a frequently fatal condition characterized by an uncontrolled and harmful host reaction to microbial infection. Despite the prevalence and severity of sepsis, we lack a fundamental grasp of its pathophysiology. Here we report that the cytokine interleukin-3 (IL-3) potentiates inflammation in sepsis. Using a mouse model of abdominal sepsis, we showed that innate response activator B cells produce IL-3, which induces myelopoiesis of Ly-6C high monocytes and neutrophils and fuels a cytokine storm. IL-3 deficiency protects mice against sepsis. In humans with sepsis, high plasma IL-3 levels are associated with high mortality even after adjusting for prognostic indicators. This study deepens our understanding of immune activation, identifies IL-3 as an orchestrator of emergency myelopoiesis, and reveals a new therapeutic target for treating sepsis.
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Sepsis is a frequently fatal condition characterized by an uncontrolled and harmful host reaction to microbial infection. Despite the prevalence and severity of sepsis, we lack a fundamental grasp of its pathophysiology. Here we report that the cytokine interleukin-3 (IL-3) potentiates inflammation in sepsis. Using a mouse model of abdominal sepsis, we showed that innate response activator B cells produce IL-3, which induces myelopoiesis of Ly-6C high monocytes and neutrophils and fuels a cytokine storm. IL-3 deficiency protects mice against sepsis. In humans with sepsis, high plasma IL-3 levels are associated with high mortality even after adjusting for prognostic indicators. This study deepens our understanding of immune activation, identifies IL-3 as an orchestrator of emergency myelopoiesis, and reveals a new therapeutic target for treating sepsis.
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nterleukin-3 (IL-3) contributes to leukocyte production, proliferation, and survival (1) (2) (3) (4) . Myeloid cells such as monocytes and neutrophils produce IL-1b, IL-6, and tumor necrosis factor-a (TNF-a), the three inflammatory hallmark cytokines constituting the cytokine storm during septic shock (5-7). Yet despite these links, IL-3's role in sepsis remains unknown. Il3 -/-mice have normal blood monocyte and neutrophil profiles ( fig. S1 , A to G) (8) and thus do not require IL-3 for myelopoiesis in the steady state. To test whether IL-3 is important in sepsis, we subjected Il3 -/-and control wild-type (WT) mice to cecal ligation and puncture (CLP), a model of polymicrobial sepsis (9) . Compared to WT mice, Il3 -/-mice were protected from sepsis, as seen in their lower mortality rates, even after antibiotic treatment (Fig. 1A) . Il3 -/-mice had better clinical scores, body temperatures (Fig. 1B) , and blood pressure (Fig. 1C) , and their recovery was associated with efficient microbial clearance, indicating that the absence of IL-3 did not compromise bactericidal activity or recognition ( Fig. 1D and  fig. S2 ).
To characterize the host response more completely, we performed time-course tissue, cellular, and molecular experiments. At 1 day after CLP, WT mice developed neutrophilia and inflammatory Ly-6C high monocytosis (Fig. 1E ), whereas in Il3 -/-mice, monocyte and neutrophil numbers remained relatively unchanged. The increased cell numbers in WT mice were associated with higher serum levels of IL-1b, IL-6, and TNF-a (Fig. 1F ). Phagocytic leukocytes were major sources of IL-1b, IL-6, and TN-Fa, because phagocyte depletion with clodronate liposomes and anti-Ly-6G before CLP abolished the cytokine storm ( fig. S3A ). However, IL-3-mediated cytokine induction was indirect: Both WT and Il3 -/-neutrophils and monocytes contained similar intracellular reservoirs of the three cytokines ( fig. S3B ). Analyzing other leukocytes showed IL-3-dependent differences in T and B cell numbers after CLP ( fig. S4A ), but no differences in basophils, mast cells (10-12) ( fig. S4 , B and C), or histamine ( fig.  S4D ), which suggests that IL-3 had little to no effect on basophil and mast cell production and function during the initial inflammationdominant phase. Consequently, WT but not Il3 -/-mice accumulated monocytes and neutrophils in the lung (Fig. 1G ) and liver (Fig. 1H) S5D ). These data show that IL-3 contributed to septic shock, the most severe form of sepsis (13, 14) . IL-3 promotes hematopoiesis by acting on its receptor, a heterodimer that consists of the IL-3-specific a chain (CD123) and the common b chain (CD131) (4 (Fig. 2D ). Although IL-3 alone modestly affected IL-1b, IL-6, and TNF-a production, combined IL-3 and LPS exacerbated the response (Fig. 2E ). These data suggest that IL-3 is responsible for the cytokine storm, albeit indirectly, by generating a large pool of cells that, upon recognizing bacterial components, produce cytokines in larger quantities.
To determine whether IL-3 can trigger severe sepsis in vivo, whether it can do so alone or in combination with infection, and whether it relies on its specific receptor, we injected (i) recombinant IL-3 (rIL-3) into otherwise healthy WT mice; (ii) anti-CD123 into WT mice subjected to CLP; and (iii) rIL-3 into Il3 -/-mice subjected to CLP.
rIL-3 augmented GMPs in the bone marrow and leukocyte numbers in the blood of healthy WT mice to levels akin to those in WT mice subjected to CLP (Fig. 2F ). Despite this increase, rIL-3 per se did not induce a cytokine storm in the absence of infection (Fig. 2G) , thus confirming our in vitro observations. Conversely, anti-CD123 attenuated cell numbers in WT CLP mice (Fig. 2F ) and tended to decrease serum cytokines (although the differences were not statistically significant) ( -/-mice receiving rIL-3 in the context of CLP augmented medullary GMP, circulating neutrophil, and Ly-6C high monocyte numbers (Fig. 2F ). These increases corresponded to higher cytokine levels in serum (Fig. 2G) . Ultimately, WT mice treated with anti-CD123 had a modest but significant improvement in survival (Fig. 2H) , whereas Il3 -/-mice receiving rIL-3 succumbed to infection and died as often as WT mice (Fig. 2I ). These data confirm the effects of IL-3 on cell production and survival and identify the IL-3-CD123 axis as a potential new therapeutic target for treating sepsis. Activated T cells (16) and thymic epithelial cells (17) produce IL-3 in the steady state, but the cytokine's source in sepsis is unknown. mRNA profiling identified the spleen, thymus, and lymph nodes as hubs of basal Il3 expression. After CLP, Il3 mRNA progressively increased in the spleen, followed by the thymus and lymph nodes, with no signal in the bone marrow, lung, liver, peritoneum, or duodenum (Fig. 3A) . As indicated by flow cytometry (Fig. 3 , B and C) and Western blots (Fig. 3D ), IL-3 + cells were CD19 + B cells. According to enzyme-linked immunosorbent assay, IL-3 levels increased in serum after CLP (Fig. 3E ) but to a lesser extent in splenectomized mice (Fig. 3E) .
Identifying B cells as sources of IL-3 prompted testing of whether IL-3-producing B cells resemble innate response activator (IRA) B cells ( fig. S8A ), whose GM-CSF (granulocyte-macrophage colonystimulating factor) product protects against sepsis and pneumonia via polyreactive immunoglobulin M (IgM) (18, 19 B cells (18) (19) (20) . The remaining, non-B IL-3-positive cells in the spleen and thymus were CD4 + T cells, CD8 + T cells, and non-T, non-B cells ( fig. S8D) .
By comparing IL-3 and GM-CSF, which are two IRA B cell products, we determined that the growth factors are not interdependent: In response to CLP, the spleens of Csf2 -/-mice accumulated IL-3-producing IRA B cells, whereas Il3 -/-mice accumulated GM-CSF-producing IRA B cells ( fig. S9A ). On the one hand, in contrast to GM-CSF (19), IL-3 was not essential to IgM production ( fig. S9 , B and C). On the other hand, unlike IL-3, GM-CSF was dispensable for emergency myelopoiesis ( fig. S9D, E) . The IL-3-producing IRA B cells were readily visualized by immunofluorescence and increased in frequency after CLP (Fig. 3, G and H, and fig. S10 ). Thus, IRA B cells can both protect against and aggravate sepsis, depending on the particular growth factor they produce. Peritoneal B1 cells relocate to the spleen after peritoneal LPS challenge (21) and differentiate to IRA B cells (18) . To determine whether IL-3 + B cells arise similarly, we transferred B1 cells from the peritoneum of naïve GFP + mice into the peritoneum of WT mice. Two days after CLP, IL-3 + (Fig. 3I) and GM-CSF + B cells ( fig. S11) 
-/-mice subjected to CLP and found increased monocyte levels, cytokine levels, and morbidity in WT B cell recipients (Fig. 3J) . Overall, the data show that IL-3-producing IRA B cells induce emergency myelopoiesis and potentiate septic shock in a mouse sepsis model. Because the validity of mouse sepsis models as mirrors of human disease has been challenged (22, 23), we sought to determine whether our experimental findings correlate with the pathogenesis of human sepsis. First, we retrospectively analyzed plasma from a cohort of septic patients [RAMMSES cohort, n = 60 (table S1) with IL-3 plasma levels >87.4 pg/ml at admission had a poor prognosis (fig. S12, A and B , and table S2). We therefore decided to test, in a new prospective cohort [SEPIL-3 cohort, n = 37 (table S3) ], whether IL-3 and blood monocytes correlate. In septic patients monitored over 28 days, blood leukocyte numbers peaked at the onset of sepsis and decreased slowly thereafter (Fig.  4A) . The increase was associated with a sharp spike of plasma cytokines (Fig. 4B) . Compared to healthy volunteers, mean IL-3 in septic patient plasma did not differ (Fig. 4C) . Nevertheless, the detectable levels of IL-3 correlated with circulating monocyte levels in septic patients (Fig.  4D) . Kaplan-Meier survival analysis showed that patients with plasma levels of >89.4 pg/ml had a poor prognosis ( fig. S13 and table S4 ), thus confirming the results from the RAMMSES cohort. Pooling the cohorts showed the impact of IL-3 on survival to be even more striking (odds ratio: 4.979; confidence interval: 1.680 to 14.738 and P = 0.001 for the Kaplan-Meier survival curve) (Fig. 4E) . The association remained significant after adjusting for prognostic parameters in multivariate analyses (table S5) , whereas multivariate logistic regression analyses consistently showed improvement in the death prediction when IL-3 was included, as shown by a reduction of the Aikake information criterion and an increase of McFadden's pseudo R 2 (table S6) . We also conducted flow cytometry and immunofluorescence on human spleens from patients undergoing splenectomy. By flow cytometry, we found CD20 + HLADR int CD19
high IgM int/high B and CD3 + T cells to be producers of IL-3 ( Fig. 4F and fig. S14A ). In tissue sections, human spleens contained IL-3-producing CD19 + and IgM + B cells (Fig. 4G and fig. S14 , B and C), suggesting that IL-3-producing IRA B cells amplify inflammation in humans as well as mice ( fig. S15) . Mortality from sepsis ranges between 30 and 50% and is rising because of drug-resistant organisms, a growing elderly population, and an increased incidence of immunosuppression (25) (26) (27) (28) . The failures of anti-Toll-like receptor 4, recombinant activated protein C, and anti-TNF-a therapies in clinical trials necessitate a rethinking of sepsis' pathophysiology (6, (29) (30) (31) (32) (33) . Because many early-phase inflammatory cytokines operate concurrently and redundantly, identifying upstream triggers may generate therapies with broad downstream benefits. Altogether, the evidence shown here supports the hypothesis that IL-3 mediates experimental and human sepsis, is a major upstream orchestrator of the septic inflammatory phase, and can be harnessed for therapeutic intervention. 
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Circadian clocks orchestrate periods of rest or activity and feeding or fasting over the course of a 24-hour day and maintain homeostasis. To assess whether a consolidated 24-hour cycle of feeding and fasting can sustain health, we explored the effect of time-restricted feeding (TRF; food access limited to daytime 12 hours every day) on neural, peripheral, and cardiovascular physiology in Drosophila melanogaster. We detected improved sleep, prevention of body weight gain, and deceleration of cardiac aging under TRF, even when caloric intake and activity were unchanged. We used temporal gene expression profiling and validation through classical genetics to identify the TCP-1 ring complex (TRiC) chaperonin, the mitochondrial electron transport chain complexes, and the circadian clock as pathways mediating the benefits of TRF.
T o determine whether a daily rhythm of feeding and fasting without reducing caloric intake can improve health metrics, we subjected a 2-week-old wild-type (WT) Oregon-R strain (table S1) of Drosophila melanogaster adults to ad libitum feeding (ALF) or 12-hour time-restricted feeding (TRF) of a standard cornmeal diet exclusively during daytime. At nighttime, the TRF cohorts were placed in vials with 1.1% agar to prevent desiccation ( fig. S1A ). The daily food intake was equivalent in both groups, although ALF flies consumed some of their food during nighttime (Fig. 1A) . Unlike ALF flies, the TRF group did not gain body weight at 5 and 7 weeks of age (Fig. 1B) . The ability to fly (flight index) was slightly improved in the TRF group (Fig. 1C) . Although the total daily activity was equivalent between both groups of flies (Fig. 1D) , the TRF flies were more active during daytime. Sleep (defined as five consecutive minutes of inactivity) (1) assessment revealed that flies on TRF had less daytime sleep, but more nighttime and more total sleep, than the ALF flies (Fig. 1E  and fig. S1 ).
Increase in sleep duration correlates with improved cardiac function (2) . Therefore, by highspeed video imaging of ex vivo denervated hearts bathed in artificial hemolymph (3), we measured the diameter of the beating Drosophila heart at full relaxation and contraction and the time interval between successive contractions to calculate cardiac function parameters ( Fig. 2A) . At 3 weeks of age, the performance of both ALF and TRF hearts was indistinguishable with equivalent heart period (HP), systolic diameter (SD), systolic interval (SI), diastolic diameter (DD), diastolic interval (DI), arrhythmia index (AI), and heart contractility, measured as fractional shortening (FS) (Fig. 2, B  to F; fig. S2 ; and movie S1). In the next 2 weeks, the cardiac performance in ALF flies exhibited characteristic age-dependent deterioration (4), with increased SI, DI, HP, and AI and reduced DD, SD, and FS. TRF flies showed smaller changes in these cardiac performance parameters in both genders ( fig. S2) .
We investigated whether a limited period of TRF early or late in life could attenuate age-dependent
